Skip to content

A Clinical study of Karasoodasathu Parpam in the management of Kalladaippu Noi (Urolithiasis)

A Prospective Open labelled non randomized phase II Clinical trial on Karasoodasathu Parpam in management of kalladaippu noi(Urolithiasis)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023632
Enrollment
60
Registered
2020-02-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N209- Urinary calculus, unspecified

Interventions

Intervention1: Karasoodasathu Parpam: 2.5-5 mgKgBWTwice a dayAf for 45 days with Honey Control Intervention1: Nil: Nil

Sponsors

Government Siddha Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Renal colicky pain from loin to groin 2.Nausea and Vomiting 3.Haemeturia 4.Oliguria 5.Dysuria 6.Patients who are willing to undergo radiological Investigations and give blood for laboratory investigations.

Exclusion criteria

Exclusion criteria: 1.Chronic Appendicitis 2.Cholecystitis 3.Pyelonephritis 4.Recurrent UTI 5.Diabetes mellitus 6.Metabolic disorders like Hyperthyroidism,Hyperparathyroidism 7.Pelvic inflammatory disease 8.Chronic Renal Failure

Design outcomes

Primary

MeasureTime frame
1.Reduction in Severity of renal colicky pain,Nausea,Vomiting,Haematuria,Dysuria,Oliguria 2.Reduction in size of the kidney stone in USG Abdomen and pelvis(In selective patients)Timepoint: 45 days

Secondary

MeasureTime frame
1.Evaluation of pharmacological ,Biochemical and Phytochemical analysis of trial drug. 2.Determination of safety profile of trial drug 3.Evaluation of additional effects and Siddha parameters changes in Kalladaippu noi.Timepoint: 45 days

Countries

India

Contacts

Public ContactDr G Subashchandran MDs

Government Siddha Medical College and Hospital

siddhadrgs21@gmail.com9443358271

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026